181 related articles for article (PubMed ID: 30893058)
1. The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma.
Levpuscek K; Goricar K; Kovac V; Dolzan V; Franko A
Radiol Oncol; 2019 Mar; 53(2):206-212. PubMed ID: 30893058
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
Betti M; Ferrante D; Padoan M; Guarrera S; Giordano M; Aspesi A; Mirabelli D; Casadio C; Ardissone F; Ruffini E; Betta PG; Libener R; Guaschino R; Matullo G; Piccolini E; Magnani C; Dianzani I
Mutat Res; 2011 Mar; 708(1-2):11-20. PubMed ID: 21277872
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
Dianzani I; Gibello L; Biava A; Giordano M; Bertolotti M; Betti M; Ferrante D; Guarrera S; Betta GP; Mirabelli D; Matullo G; Magnani C
Mutat Res; 2006 Jul; 599(1-2):124-34. PubMed ID: 16564556
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract][Full Text] [Related]
5. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression.
Yu T; Xue P; Cui S; Zhang L; Zhang G; Xiao M; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Cancer Med; 2018 Dec; 7(12):6317-6330. PubMed ID: 30453383
[TBL] [Abstract][Full Text] [Related]
6. DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
Erčulj N; Kovač V; Hmeljak J; Franko A; Dodič-Fikfak M; Dolžan V
J Thorac Oncol; 2012 Oct; 7(10):1609-17. PubMed ID: 22982660
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers.
Zhao XH; Jia G; Liu YQ; Liu SW; Yan L; Jin Y; Liu N
Biomed Environ Sci; 2006 Jun; 19(3):232-8. PubMed ID: 16944782
[TBL] [Abstract][Full Text] [Related]
8. Study of association between pre-senile cataracts and rs11615 of ERCC1, rs13181 of ERCC2, and rs25487 of XRCC1 polymorphisms in a Spanish population.
López-Valverde G; Garcia-Martin E; Fernández-Mateos J; Cruz-González F; Larrosa-Povés JM; Polo-Llorens V; Pablo-Júlvez LE; González-Sarmiento R
Ophthalmic Genet; 2017; 38(4):314-319. PubMed ID: 27668351
[TBL] [Abstract][Full Text] [Related]
9. DNA repair genes XRCC1 and ERCC1 polymorphisms and the risk of sporadic breast cancer in Han women in the Gansu Province of China.
Zhu G; Wang L; Guo H; Lu L; Yang S; Wang T; Guo H; Wang H; Min J; Yang K; Chen X; Liu Y; Wang Z; Su H
Genet Test Mol Biomarkers; 2015 Jul; 19(7):387-93. PubMed ID: 25961110
[TBL] [Abstract][Full Text] [Related]
10. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.
Zhou W; Liu G; Park S; Wang Z; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):491-6. PubMed ID: 15734977
[TBL] [Abstract][Full Text] [Related]
11. DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma.
Han JY; Yoon KA; Park JH; Lee YJ; Lee GK; Han JH; Yoon SJ; Yun T; Kim HT; Lee JS
Cancer; 2011 Jul; 117(14):3201-8. PubMed ID: 21264830
[TBL] [Abstract][Full Text] [Related]
12. Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population.
Xue P; Gao L; Xiao S; Zhang G; Xiao M; Zhang Q; Zheng X; Cai Y; Jin C; Yang J; Wu S; Lu X
PLoS One; 2015; 10(12):e0144458. PubMed ID: 26681190
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
Neri M; Ugolini D; Dianzani I; Gemignani F; Landi S; Cesario A; Magnani C; Mutti L; Puntoni R; Bonassi S
Mutat Res; 2008; 659(1-2):126-36. PubMed ID: 18420450
[TBL] [Abstract][Full Text] [Related]
14. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
15. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies.
Ding YW; Gao X; Ye DX; Liu W; Wu L; Sun HY
Clin Transl Oncol; 2015 Sep; 17(9):710-9. PubMed ID: 26022132
[TBL] [Abstract][Full Text] [Related]
16. Distribution of nucleotide variants in the DNA sequence of ERCC1 and XRCC1 genes and the effect of phenotype in patients with gastric cancer.
Asgerov E; Şenol Ö; Güler A; Berdeli A
Turk J Gastroenterol; 2019 Jun; 30(6):517-523. PubMed ID: 31144657
[TBL] [Abstract][Full Text] [Related]
17. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
[TBL] [Abstract][Full Text] [Related]
18. ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma.
Hirakawa H; Ikegami T; Azechi S; Agena S; Uezato J; Kinjyo H; Yamashita Y; Tanaka K; Kondo S; Maeda H; Suzuki M; Gahana A
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):601-610. PubMed ID: 31749055
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
[TBL] [Abstract][Full Text] [Related]
20. The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk.
Chen LH; Shen TC; Li CH; Chiu KL; Hsiau YC; Wang YC; Gong CL; Wang ZH; Chang WS; Tsai CW; Hsia TC; Bau DT
Cancer Genomics Proteomics; 2020; 17(5):571-577. PubMed ID: 32859635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
